FONR Overview

FONAR Corporation is engaged in the research, development, production and marketing of medical scanning equipment, which uses principles of Magnetic Resonance Imaging (MRI) for the detection and diagnosis of human diseases. The Company conducts its business in two segments: medical equipment and physician management and diagnostic services. Its medical equipment segment is conducted directly through the Company. Its physician management and diagnostic services segment is conducted through its subsidiary, Health Management Corporation of America (HMCA). Its signature product is the FONAR UPRIGHT Multi-Position MRI (STAND-UP MRI). HMCA provides management services, administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, hiring, maintenance service, and clerical and other non-medical personnel to medical providers engaged in diagnostic imaging. HMCA owns and operates six diagnostic imaging facilities in Florida.

Wall Street analysts forecast FONR stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for FONR is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Fonar Corp revenue for the last quarter amounts to 25.55M USD, increased 2.39

Fonar Corp. EPS for the last quarter amounts to 0.29 USD, increased 7.41

Fonar Corp (FONR) has 535 emplpoyees as of March 12 2026.

Today FONR has the market capitalization of 116.44M USD.